SynthesisFrontiers in psychology2025
Fear of cancer recurrence in oncohematological patients: assessment instruments and evidence-based psychological interventions - a systematic review.
Synthesis in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- How prevalent is fear of cancer recurrence beyond 5 years: a systematic review of validated assessments across tumour types.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Pooled it
- Association of social restrictions with fear of cancer recurrence in hematopoietic stem cell transplantation patients: an exploratory analysis of the potential chain mediation role of illness perception and cognitive emotion regulation.Frontiers in psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Oncohematological patients undergo a complex emotional adaptation process, in which Fear of Cancer Recurrence (FCR) is one of the most prevalent concerns. This fear not only negatively impacts their psychological well-being but is also associated with a significant reduction in quality of life. Objective: This study aims to conduct a systematic review of the available evidence regarding: (1) The factors associated with FCR in oncohematological patients. (2) The validity and reliability of the instruments used for its assessment. (3) The therapeutic interventions designed to mitigate FCR in this population, with particular focus on those supported by solid empirical evidence. Methodology: A systematic review was conducted following the PRISMA guidelines. The literature search was performed in November 2024 across the PubMed, PsycINFO, Web of Science, ProQuest, SUMMON, SciELO, Redalyc, Dialnet, and Google Scholar databases. Rigorous inclusion and exclusion criteria were applied to ensure the methodological quality of the selected studies. Results: After the selection process, 11 studies meeting the eligibility criteria were included. The main findings were: (a) FCR assessment instruments: Four validated tools specifically designed for oncohematological populations were identified. (b) Therapeutic interventions: Four programs based on cognitive-behavioral therapy and third-wave therapies were found to be effective in reducing FCR in patients with leukemia, lymphoma, and multiple myeloma. Conclusion: This systematic review provides a comparative evaluation of measurement methods and the most effective interventions for addressing FCR in oncohematological patients. The findings highlight the need for further research tailored to the specific characteristics of this population, fostering the development of more precise and accessible therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.